Table 1 Characteristics of studies included in the meta-analysis
Author/s (reference) | Study design | Reginal state | sample size | Male | Female | Prevalence of types of ACS | In-hospital mortality | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
STEMI | NSTEMI | UA | Total | STEMI | NSTEMI | UA | ||||||
Desta et al., 2020 (21) | R. cross-sectional study | Tigray | 151 | 109.00 | 42.00 | 72.80% | 15.20% | 12.0% | 37.00 | 25.00 | 9.00 | 3.00 |
Bogale et al., 2019 (22) | R. cross-sectional | AA | 124 | 94.00 | 30.00 | 72.60% | 16.10% | 11.30% | 34.00 | 32.00 | 1.00 | 1.00 |
Tsegaye et al., 2021 (23) | R. cohort study | AA | 471 | 315.00 | 156.00 | 32.98% | 28.30% | 38.9% | 4.00 | N/A | N/A | N/A |
Hailu et al., 2020 (24) | R. cross-sectional | AA | 67 | 151 | 29.00 | N/A | N/A | N/A | 5.00 | N/A | N/A | N/A |
Fanta et al., 2021 (25) | P. observational | Oromia | 181 | 113.00 | 68.00 | 61% | 39% | 0 | 46.00 | 35.00 | 11.00 | 0.00 |
Giday et al., 2013 (26) | R. cross-sectional | AA | 21 | 16 | 5.00 | 62% | 28.60% | 9.40% | 3.00 | 2.00 | 1.00 | 0.00 |
Wakwaya et al., 2019 (27) | R. cross-sectional | AA | 40 | 29.00 | 11.00 | 67.50% | 17.50% | 15% | 4.00 | N/A | N/A | N/A |
Mebrahatom et al. (28) | R. cross-sectional | AA | 142 | 99.00 | 43.00 | 48.60% | 20.40% | 31% | 14.00 | 12.00 | 1.00 | 1.00 |